| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |